Table 3.
Study | Clinical trial design | Clinical condition | Intervention | Comparison | Acupoints | Acupuncture parameters | Outcomes |
---|---|---|---|---|---|---|---|
Chae et al. (2009) [98] | Controlled trial | PD patients (mild) | Verum acupuncture (n = 10) | Covert placebo/overt placebo (n = 10) | Left GB34 | 10 mm, manually rotated clockwise and counterclockwise once per second (1 Hz), 60 seconds, then withdrawn for 120 seconds, only once | The putamen and the primary motor cortex↑, motor function↑ (VA vs. CP) |
| |||||||
Yeo et al. (2012) [99] | RCT | Idiopathic PD patients | Acupuncture (n = 12) | Acupuncture on healthy participants (n = 12) | Right GB34 | 1 cm, remained in the skin for 1 min and rotated bidirectionally for 1 min, needle remained in the skin without rotation for 1 min and then the pattern of 1 min rotation and 1 min rest was repeated, only once | Neural responses in the SN, caudate, thalamus, and putamen (impaired caused by PD)↑ |
| |||||||
Yeo et al. (2014) [100] | RCT | Idiopathic PD patients | Acupuncture (n = 12) | Acupuncture on healthy participants (n = 12) | Right GB34 | 1 cm, for “stimulated” blocks: rotated bidirectionally at 1 Hz; for “not stimulated” blocks: the needle was only inserted into the skin and then left in place, only once | Neural responses in the prefrontal cortex, precentral gyrus, and putamen in PD patients↑ |
| |||||||
Li et al. (2018) [101] | Controlled trial | PD patients with tremor | Acupuncture+L-DOPA (n = 14) | Sham acupuncture+L-DOPA (n = 14) | DU20, bilateral GB20, and the chorea-tremor controlled zone | 2-3 cm, reinforcing-reducing method, twirling every 10 minutes, 30 minutes, twice weekly, 12 weeks | Clinical evaluation: UPDRS (II and III) scores↓, neural responses (SN, caudate, thalamus, and putamen)↑ |
| |||||||
Huang et al. (2010) [102] | RCT | PD patients | Acupuncture+L-DOPA (n = 5) | L-DOPA (n = 5) | Bilateral MS6, MS4, MS8, MS9, MS14 | Continuous wave, 50 Hz, 2-4 mA, 30 minutes, six times a week, 5 weeks | rCBF (the frontal lobe, the occipital lobe, the basal ganglion, and the cerebellum in the most affected hemisphere)↑ |
| |||||||
Huang et al. (2009) [103] | RCT | PD patients | Acupuncture+Madopar (n = 5) | Madopar (n = 5) | Bilateral MS6, MS4, MS8, MS9, MS14 | Continuous wave, 50 Hz, 2–4 mA, 30 minutes, six times a week, 5 weeks | The glucose metabolisms (parietal, temporal, occipital lobes, the thalamus, and the cerebellum in the light-diseased hemisphere, and in parietal and occipital lobes of the severe-diseased hemisphere)↑ |
PD: Parkinson's disease; GB34: Yanglingquan; VA: verum acupuncture; CP: covert placebo; RCT: randomized controlled trial; SN: substantia nigra; L-DOPA: levodopa; DU20: Baihui; GB20: Fengchi; UPDRS: Unified Parkinson's Disease Rating Scale; MS6: the anterior oblique line of the vertex to temple; MS4: the lateral line III on forehead; MS8: the lateral line I of the vertex; MS9: the lateral line II of the vertex; MS14: the lower-lateral line of the occipital scalp; rCBF: regional cerebral blood flow.